Smash Notes

Back to Biohub: The Future of Biology is Open-Source with Co-Founders Mark Zuckerberg, Priscilla Chan, and Head of Science Alex Rives, with Priscilla Chan & Mark Zuckerberg.

Can a Model Predict Where a Drug Will Bind?

Alex Rives says a model that can simulate where a drug distributes and binds across the body is the beginning of a solution to toxicity.

The step he is describing is the move from ESM Fold 2 to a model that can design a molecule and send it toward the clinic with a much better hit rate. Figuring out how to optimize a drug, how to get it through preclinical work, and how to do the early safety check are problems people could spend an entire career on. A new scientific paradigm simplifies questions that were once hard, and he expects many of those problems to be solved in an emergent way. Accurate representations at the molecular level are what he says will start that rapid progress.

Transcript

Biohub: The Future of Biology is Open-Source with Co-Founders Mark Zuckerberg, Priscilla Chan, and Head of Science Alex Rives ·

From the transcript

And then so there's this one piece, which is fundamental understanding. And then there's this like theory of someday we're just going to be able to like zero shot things into either the clinic or the clinic with much, much better hit rate. What needs to happen for us to go from ESM Fold 2 to this other piece? Is that feasible? I think that's a great question.

I mean, I would say that I'm really optimistic on that. So I think, you know, on the one hand, you know, these are problems that historically, you know, people could spend kind of an entire career working on. Like, how do you figure out how to effectively optimize a drug? How do you get it, you know, get it through preclinical? How do you do the early safety approach? I think that when you have a new scientific paradigm, questions that were once hard become simplified through the new paradigm.

See in transcript

No Priors: Artificial Intelligence | Technology | Startups

More from this episode

  1. Why Does Biohub Build Tools Instead of Cures?Priscilla Chan says Biohub's goal is to build tools that accelerate whole scientific fields so the field can collectively cure disease, and Biohub is not the…
  2. How Does Biohub Model Biology From Proteins Up?Mark Zuckerberg says each layer of biology ends up qualitatively different, so Biohub builds models from proteins upward instead of jumping straight to cells.
  3. Why Does Biohub Release Biology Models as Open Source?Mark Zuckerberg says Biohub releases its biology models as open source so more scientists get the tools sooner, which he expects will move the field faster…
  4. Why Does Biohub Study Systems Instead of One Disease?Mark Zuckerberg says Biohub studies systems such as inflammation and the immune system, rather than one disease, so other groups can use the tools on specific…
  5. How Does Biohub's Protein Model Design Antibodies?Alex Rives says Biohub's new ESM fold model designs single-chain antibodies on a computer, and a lab test of 96 proteins found nanomolar binders, the level…
  6. Why Was Baby KJ's Therapy Aimed at the Liver?Priscilla Chan says baby KJ's disease was chosen because the therapy had to reach his liver, where a product could be delivered.
  7. How Would Biohub's Virtual Cell Link Genes to a Phenotype?Alex Rives says Biohub's virtual cell would model each level of biological complexity and connect the proteomic layer, the genetic layer, and the…

People

More answers like this

The other side

More with Sarah Guo

More with Elad Gil

Related episodes

Plays from this note through the rest of the episode.

Weekly highlights

One letter a week.

The notes worth hearing, with the minute they were said.